Introduction {#s1}
============

Celiac disease (CD) is an autoimmune disorder triggered by the ingestion of gluten that, in genetically predisposed individuals, leads to damage of the small intestine and consequent malabsorption. Most patients (95% of them) are carriers of the DQ2 or DQ8 haplotype of the histocompatibility complex class II human leukocyte antigen (Lebwohl et al., [@B75]). Tissue transglutaminase (tTG) is the main auto-antigen (Alaedini and Green, [@B4]), whereas gut histopathology shows variable degrees of small bowel mucosal villi atrophy. CD affects 0.3--1.5% of the general population (approximately 1 of 120--300 people in Europe and America) (Morello et al., [@B86]; Bingley et al., [@B13]). To date, the only established therapy is a lifetime dietary gluten restriction, which is usually followed by relief of several clinical manifestations, normalization of histological and serological markers, as well as decreased risk of associated malignant and non-malignant complications (Holmes, [@B61], [@B62]).

Clinically, although diarrhea and other gastro-intestinal symptoms can commonly be observed at disease onset or in its early phases in both pediatric patients and young adults, they are not as frequent as in the past (Campagna et al., [@B22]). Many adults (\>50%) exhibit significant extra-intestinal involvement even without typical CD manifestations (Cooke and Smith, [@B38]; Hadjivassiliou et al., [@B50], [@B57], [@B52]; Bushara, [@B20]; Uygur-Bayramicli and Ozel, [@B116]; Castillo et al., [@B31]). Therefore, CD is considered a complex systemic disorder with multifactorial pathogenesis that should be investigated from genetic, biological, and environmental perspectives.

Currently, little is known about the neurophysiology of central nervous system (CNS) damage in CD. This review aims to summarize the electrophysiological evidence on CNS functioning and pathology, including the clinical and instrumental response to a gluten-free diet (GFD).

Neurological complications of celiac disease: a brief overview {#s2}
==============================================================

Nowadays, it is widely accepted that the typical disease represents a small proportion of the so-called "CD iceberg," because 5--6 fold more patients present with atypical or silent forms (Green et al., [@B47]). Neurological manifestations may either precede or follow the disease, or be present at its onset (Hadjivassiliou et al., [@B50], [@B57], [@B52]; Briani et al., [@B16]). Therefore, a sensitive and specific diagnostic method able to recognize early disease process, progression, and complication would be desirable.

To date, both the causative factors and pathophysiological mechanisms of neurological involvement in CD remain a matter of debate. According to the literature, the nervous system may be one of the elective sites of gluten-mediated pathogenesis, including cross-reacting antibodies, immune-complex deposition, direct neurotoxicity, other immune-mediated factors, and deficiency of vitamin and other nutrients secondary to chronic malabsorption (Zelnik et al., [@B120]; Bushara, [@B20]; Abenavoli, [@B1]; Parisi et al., [@B90]). Recently, studies using single photon emission computed tomography showed regional changes in cerebral perfusion, with regression after institution of a GFD (De Santis et al., [@B41]; Usai et al., [@B114]). The authors argued that the cerebral hypoperfusion might be related to intestinal hyperemia from immune-mediated or endothelial damage due to immune-complex deposition likely involving antibodies against gliadin (De Santis et al., [@B41]). Alternatively, cortical brain hypoperfusion could reflect focal vasculitis secondary to perivascular inflammation (Usai et al., [@B114]).

Cerebellar ataxia
-----------------

"Gluten ataxia" is one of the first recognized symptoms (Cooke and Smith, [@B38]) and the most frequent neurological disturbance in CD (Hadjivassiliou et al., [@B56]). Dysarthria, cortical-spinal signs, eye and gaze movement disorders, and cerebellar ataxia are representative presentations. Recent studies showed deposits of antibodies against tTG on cerebellar blood vessels, adding support to a blood-brain barrier (BBB) dysfunction in CD (Hadjivassiliou et al., [@B55], [@B56]). Interestingly, gluten ataxia is not usually related to intestinal manifestations or vitamin deficiency, and improvement with a GFD is possible (Hadjivassiliou et al., [@B55]).

Peripheral neuropathy
---------------------

Peripheral neuropathy is the second most common neurological manifestation of CD (up to half of patients) after cerebellar ataxia, and can appear even before diagnosis (Chin et al., [@B33]; Chin and Latov, [@B32]). Studies on the effect of a GFD on peripheral neuropathy are conflicting, with some authors reporting clinical improvement whereas others concluding a lack of relevant response (Luostarinen et al., [@B82]; Siqueira Neto et al., [@B107]). A previous study on 32 consecutive adult patients complaining of peripheral neuropathy, autonomic dysfunction, or both, and showing anti-neuronal antibodies found no response despite the adoption of a GFD (Tursi et al., [@B113]).

Epilepsy
--------

A bidirectional link between epilepsy and CD has been established in several studies, although not all (Vieira et al., [@B118]), with rates of prevalence from 3.5 to 7.2% (Cooke and Smith, [@B38]; Zelnik et al., [@B120]; Bushara, [@B20]; Uygur-Bayramicli and Ozel, [@B116]; Hadjivassiliou et al., [@B52]; Parisi et al., [@B90]). A large population-based cohort study observed an increased risk of CD in subjects of all ages, including children, even when epilepsy was independently restricted to patients receiving the diagnosis of epilepsy and those with prescriptions of antiepileptic drugs (Ludvigsson et al., [@B81]). The hypotheses accounting for epilepsy in CD included a gluten-mediated toxicity, an immune-induced cortical damage, the presence of cerebral calcifications, and vitamins/trace elements malabsorption. GFD usually controls seizures refractory to antiepileptic drugs (Hadjivassiliou et al., [@B50]; Canales et al., [@B23]). CD-related progressive ataxia is associated with stimulus-sensitive myoclonus, opsoclonus-myoclonus, and sometimes with seizures (Borg, [@B15]; Deconinck et al., [@B40]).

Headache
--------

It has been reported that a GFD results in complaints of less severe headache symptoms by celiac patients (Hadjivassiliou et al., [@B54]). Accordingly, structural and functional neuroimaging studies were in favor of an association between migraine and CD, with relief after gluten restriction (Hadjivassiliou et al., [@B54]). However, when headaches in CD patients were compared with those in the general population, a conclusive association was not proven (Nikpour, [@B89]).

Cognitive impairment and dementia
---------------------------------

Adult CD patients often complain of mild cognitive symptoms called "brain fog," which improves when gluten-restriction is started, but re-appears with dietary contamination (Lichtwark et al., [@B77]; Yelland, [@B119]). Concentration and attention difficulties, episodic memory deficits, word-retrieval problems, reduced mental acuity, and episodes of confusion or disorientation are the commonly reported features (Lurie et al., [@B83]). In some severely affected patients, dementia can develop as acalculia, confusion, amnesia, and personality disorders (Collin et al., [@B35]; Hu et al., [@B63]; Lurie et al., [@B83]; Casella et al., [@B30]). Despite long-term administration of a GFD, patients older than 65 years exhibited worse cognitive performance than age- and sex-matched controls (Casella et al., [@B30]).

Neuropsychiatric disorders
--------------------------

Several psychiatric symptoms, including depression, bipolar disorder, apathy (Carta et al., [@B28], [@B26]; Cicarelli et al., [@B34]), excessive anxiety (Bushara, [@B20]; Campagna et al., [@B22]), irritability (Hernanz and Polanco, [@B60]), schizophrenia (De Santis et al., [@B41]; Bushara, [@B20]), eating disorders (Addolorato et al., [@B2]), attention-deficit/hyperactivity disorder (Karwautz et al., [@B68]), autism (Niederhofer and Pittschieler, [@B88]), and sleep complaints (Barcia et al., [@B5]) have been associated with CD.

Reactive anxiety that usually ameliorates with a GFD is the predominant form of anxiety disorder in these patients. Depressive disturbances, which affect a relevant number of subjects, may significantly impair quality of life, and are a good predictor of lack of dietary compliance (Zingone et al., [@B122]). Therefore, screening patients for depression is of pivotal importance both at diagnosis and follow-up in order to advice psychological support and/or pharmacological therapy. Possible causative factors of mood disorders might be tryptophan deficiency secondary to chronic malabsorption (Hallert et al., [@B58]; Hernanz and Polanco, [@B60]) or co-morbidity with thyroid disease (Carta et al., [@B27]). Decreases in levels of serotonin, dopamine, and noradrenaline metabolites in cerebrospinal fluid as well as tryptophan and other monoamine precursors in serum were observed in untreated patients (Hallert et al., [@B58]; Hernanz and Polanco, [@B60]).

Clinical improvement was reported only after long-term administration of a GFD (\>5 years) (van Hees et al., [@B117]), highlighting the importance of prolonged alimentary restriction on extra-intestinal CD symptoms as well.

Neurophysiological techniques used to probe CNS involvement in celiac disease {#s3}
=============================================================================

Electroencephalography
----------------------

The spectrum of electroencephalography (EEG) features associated with CD is rather wide, although focal activity in terms of unilateral or bilateral spike or slow waves, mainly localized in the occipital regions, have been reported in most of the wakefulness EEG studies (Magaudda et al., [@B84]; Labate et al., [@B69]; Pratesi et al., [@B101]; Ranua et al., [@B102]; Lionetti et al., [@B78]; Licchetta et al., [@B76]; Aksoy et al., [@B3]). However, as recommended (Parisi et al., [@B91]), EEG patterns should not be considered disease-specific.

A recent prospective study among 307 CD children compared with 197 age- and sex-matched controls observed that patients were more prone to epileptiform activities on EEG (spike/sharp-wave discharges, especially in the occipital lobes but also in the central-temporal sites and in diffuse distribution). However, early and strict adherence to a GFD effectively decreased these findings (Işıkay et al., [@B64]). In addition, a positive correlation between tTG level and epileptiform changes during sleep and awake EEG was found (Işıkay et al., [@B64]). The concept that the occipital region is frequently involved in CD seems to be supported by the evidence of occipital calcium deposition, occipital lobe semiology, and EEG findings. The preferential involvement of this lobe may lie on several factors, such as its vulnerability to some metabolic circumstances (e.g., hypoglycemia and hypoxia) and its thinner morphological structure than other cortical regions (Işıkay et al., [@B65]). However, the opposite scenario (the occurrence of CD in patients with "posterior" epileptic semiology) is not always true because in a group of 90 pediatric epileptic patients with occipital EEG abnormalities, tTG antibody was positive in only two (Canales et al., [@B23]).

CD-associated epilepsy has also been reported in association with other neurological signs, such as ataxia, tremor, and progressive myoclonus (Javed et al., [@B66]; Sarrigiannis et al., [@B105]). In these cases, epilepsy was usually refractory, and EEG demonstrated spike and waves in the right anterior and mid-temporal lobes, as well as bilateral slow and sharp waves. Some of these spike waves were present in association with localized jerks of the upper or lower limb, although without periodic complexes (Javed et al., [@B66]; Sarrigiannis et al., [@B105]). Finally, the fixation-off sensitivity phenomenon could be observed (Casciato et al., [@B29]).

In regard to the impact of dietary restriction, a recent study in 19 children with biopsy-proven CD revealed abnormal EEG findings in 48% of them that were no longer evident in most of the patients after 6 months of GFD (Parisi et al., [@B90]). However, some asymptomatic children and adolescents still manifested hyperexcitability to EEG despite the diet (Parisi et al., [@B90]).

In summary, CD screening should be performed in patients with cryptogenic and/or refractory epilepsy, or in the presence of unexplained EEG findings. Gluten restriction is usually effective in ameliorating the clinical-instrumental correlates.

Evoked potentials
-----------------

Few studies, most of which used somatosensory evoked potentials (SEPs), have explored CD with evoked potentials. Di Lazzaro and co-workers reported a patient whose lower limb SEPs presented enlargement of lumbar waves and bilateral lack of cortical responses, suggesting an impaired somatosensory conduction along the spinal dorsal columns; GFD induced complete clinical-instrumental recovery (Di Lazzaro et al., [@B42]). Another case presented one child with prolonged central conduction time among 27 treated children (Cakir et al., [@B21]). In patients with cerebellar ataxia associated with subclinical CD responding to a GFD, normal SEPs were reported (Pellecchia et al., [@B94]). However, in a large cohort of adult ataxic patients, more than half had loss or delayed P40 cortical response, suggesting dorsal column degeneration (Bürk et al., [@B18]). In regard to SEPs in cortical mycolonus, a previous study in two CD-proven subjects with myoclonic ataxic syndrome showed giant and time-locked cortical responses that preceded the myoclonus (Tijssen et al., [@B109]). The authors speculated that, in spite of the neurophysiological evidence of cerebral cortical involvement, the hyperexcitability was mainly located in the cerebellum, and that the effects on sensory-motor cortex represented a remote influence from cerebellar dysfunction (Tijssen et al., [@B109]). Conversely, the cortical electrophysiological origin of the myoclonus was argued by other researchers who found their patients responded poorly to a GFD and worsened progressively (Lu et al., [@B79]; Tison et al., [@B110]; Bhatia et al., [@B12]).

Although CD may impact the auditory system (Bürk et al., [@B18]), brainstem auditory evoked potentials (BAEPs) and vestibular evoked myogenic potentials were reported to be normal (Pawlak-Osińska et al., [@B93]). More recently, it was found that only 1 of 25 patients had abnormalities in BAEPs in terms of moderate sensorineural hearing loss (Aksoy et al., [@B3]).

Complications affecting visual pathways may develop in CD and be evidenced by visual evoked potentials (VEPs) (Bürk et al., [@B18]; Freeman, [@B44]; Hadjivassiliou et al., [@B57]). In particular, patients can show abnormalities on VEPs without evident lesions at neuroimaging (Aksoy et al., [@B3]). A previous case described a slight increase of P100 wave latency bilaterally at pattern-reversal VEPs that reverted back to normal after a GFD (Pellecchia et al., [@B94]). Given their role in detecting even preclinical pathology in subjects with normal ophthalmological and brain imaging exams, VEPs may provide useful insights in neurologically asymptomatic CD patients (Aksoy et al., [@B3]).

Transcranial magnetic stimulation
---------------------------------

In 1999, Pellecchia and co-workers first reported motor evoked responses to transcranial magnetic stimulation (TMS) in a CD patient who exhibited reduced amplitude in the rectus femoris muscle that improved with diet; however, motor responses remained undetectable in the tibialis anterior muscle (Pellecchia et al., [@B94]). A year later, report of delayed motor response in the left tibialis anterior muscle and abnormal cortical inhibition was published in one of three CD patients with cortical myoclonus (Tijssen et al., [@B109]).

Specific TMS studies before and after GFD were published more recently. TMS is an electrophysiological tool able to non-invasively explore the excitation state of motor cortical areas and conductivity of the pyramidal tract *in vivo*. Moreover, it is capable of unveiling subclinical central motor involvement in different neurological and psychiatric diseases or systemic disorders affecting the CNS (Bella et al., [@B7],[@B9], [@B6]; Pennisi et al., [@B96],[@B97], [@B95], [@B99]; Concerto et al., [@B37]; Lanza et al., [@B71], [@B73],[@B74], [@B70],[@B72]; Cantone et al., [@B25], [@B24]), also providing prognostic (Bella et al., [@B8]; Pennisi et al., [@B100]) and therapeutic implications (Spampinato et al., [@B108]; Concerto et al., [@B36]; Bordet et al., [@B14]). Lastly, the so-called "pharmaco-TMS" can selectively probe the functioning of different central neurotransmission pathways, such as glutamate, gamma-aminobutyric-acid (GABA), monoamine, and acetylcholine, by testing their pharmacological agonists or antagonists (Paulus et al., [@B92]; Ziemann et al., [@B121]).

The first TMS study investigated 20 *de novo* CD patients without apparent neurological involvement and 20 age-matched controls (Pennisi et al., [@B98]). TMS revealed cortical motor disinhibition and hyperfacilitation, which is a profile compatible with dysfunctional GABAergic and glutamatergic transmissions, in patients. The authors hypothesized that an imbalance of excitatory and inhibitory circuits within the motor cortex might be the neurochemical correlate of the cross-interaction between antibodies against gliadin and specific neuronal antigens. An alternative explanation was the deposition of tTG-immunoglobulin leading to an abnormal ion levels across neuronal membrane. Likewise, antibodies synthesized within the CNS and directed against glutamic acid decarboxylase might disrupt the functioning of GABAergic interneurons (Pennisi et al., [@B98]).

The same cohort of patients underwent re-evaluation after a relatively short time of a GFD (median of 16 months) (Bella et al., [@B10]). Their gastrointestinal symptoms were ameliorated but, unexpectedly, the cortical excitability to TMS further increased. This finding was hypothesized to represent a plastic re-organization of the cerebral cortex triggered by gluten exposure and independent of GFD. On the other hand, diet duration or compliance might not have been enough to induce an adequate remission (Bella et al., [@B10]). A recent cross-sectional TMS study after a much longer GFD (mean period of 8.35 years) showed that a more prolonged period of gluten restriction was required to revert the cortical changes in adult CD patients. Nevertheless, regardless of diet, some specific excitatory features to TMS remained, probably suggesting an intracortical synaptic rearrangement, mostly involving glutamate-mediated interneurons (Pennisi et al., [@B99]).

Discussion {#s4}
==========

The main translational value of this review is that clinical neurophysiology can contribute to the diagnosis, assessment, and monitoring of CD even in patients with subclinical CNS involvement or unexplained neurological symptoms (Table [1](#T1){ref-type="table"}, Figure [1](#F1){ref-type="fig"}). In particular, the majority of electrophysiological changes are often subclinical ("celiac iceberg"), and these need to be strictly monitored because of the possibility of progression to clinically visible neurological syndrome in both young and adult patients ("symptomatic celiac disease"). Accordingly, it has been shown that there is an increased risk of neurological complications in atypical or silent CD forms, especially in older patients or those older at diagnosis (Aksoy et al., [@B3]). It is worth noting that, despite their valuable role, anti-ganglioside antibodies and neuronal antigens are not always specifically linked to the neurological manifestations and their progression in the course of CD (Kaplan et al., [@B67]; Gobbi et al., [@B46]; Hadjivassiliou et al., [@B53], [@B51]; Aksoy et al., [@B3]).

###### 

Studies using electrophysiological techniques probing the central nervous system involvement in patients with celiac disease.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Study**                       **Number of patients**                 **Sex**         **Age (years)**                **Neurological features**                                                                                                                        **Neurophysiology**                          **Main results**                                                                                                                                                                        **Response to GFD**                                                                         **Translational value**
  ------------------------------- -------------------------------------- --------------- ------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------
  Lu et al., [@B79]               2                                      M/F             M: 42/F: 54                    Action limbs myoclonus, seizures, ataxia                                                                                                         a\) EEG\                                     a\) M: bilateral high-amplitude spike and polyspike discharges; F: normal\                                                                                                              No response                                                                                 First evidence of electrocortical pathology in CD
                                                                                                                                                                                                                                                                         b) SEPs                                      b) M: cortical responses greatly enlarged that preceded spontaneous muscle jerks, consistent with cortical reflex myoclonus; F: enlarged response on contralateral sensory-motor area                                                                                               

  Tison et al., [@B110]           1                                      F               56                             Arm, neck, face stimulus-sensitive and palatal myoclonus, cerebellar ataxia                                                                      a\) EEG (back averaging)\                    a\) Cortical contralateral spike slow waves preceding myoclonus\                                                                                                                        No response                                                                                 Myoclonus as a prominent feature of CD encephalopathy
                                                                                                                                                                                                                                                                         b) SEPs\                                     b) Increased P1-N2 amplitude response\                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                         c) VEPs\                                     c) Normal\                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                         d) BAEPs                                     d) Normal                                                                                                                                                                                                                                                                           

  Magaudda et al., [@B84]         8                                      5 F/3 M         Mean 17.5 (range 10-23)        Epilepsy                                                                                                                                         EEG                                          Spike and spike-waves in one or both parietal-occipital regions                                                                                                                         Seizures disappeared in 1 patient; 2 patients did not respond. Other data not reported      Electrophysiological finding of hyperexcitable posterior cerebral regions in CD

  Bhatia et al., [@B12]           4                                      1 F/3 M         Mean 57.5 (range 44-68)        Progressive myoclonic ataxic syndrome                                                                                                            a\) EEG (back averaging)\                    a\) Cortical reflex and/or action myoclonus\                                                                                                                                            Clinical progression despite strict diet                                                    Although the myoclonus was cortical, the electrophysiological origin was in the cerebellum
                                                                                                                                                                                                                                                                         b) SEPs                                      b) Enlarged cortical SEPs                                                                                                                                                                                                                                                           

  Mumford et al., [@B87]          1                                      M               44                             Myoclonic ataxia, seizures                                                                                                                       EEG                                          Frequent runs of bilateral High-voltage delta wave activity                                                                                                                             No response                                                                                 Patients with progressive ataxia and myoclonus should have a biopsy for CD

  Pellecchia et al., [@B94]       1                                      M               34                             Progressive cerebellar ataxia                                                                                                                    a\) TMS\                                     a\) Reduced amplitude of motor responses\                                                                                                                                               VEPs returned to normal after 2 years diet; partial response of TMS                         Impairment of central visual and motor pathways in CD
                                                                                                                                                                                                                                                                         b) VEPs\                                     b) Bilateral increase of P100 latency\                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                         c) SEPs                                      c) Normal                                                                                                                                                                                                                                                                           

  Tijssen et al., [@B109]         2                                      M               50                             Myoclonic ataxic syndrome                                                                                                                        a\) SEPs\                                    a\) Enlarged cortical SEPs\                                                                                                                                                             Not reported                                                                                The enhanced excitability of sensory-motor cortex may arise as a remote effect of cerebellar pathology in CD
                                                                                                                                                                                                                                                                         b) EEG (back averaging)\                     b) Time-locked cortical potential preceding the action myoclonus\                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                         c) TMS (1 patient)                           c) Delayed response in the left tibialis anterior and abnormal cortical inhibition                                                                                                                                                                                                  

  Fung et al., [@B43]             1                                      F               48                             Unilateral limb tremor, dystonia, myoclonus, and ataxia                                                                                          a\) EEG\                                     a\) Normal\                                                                                                                                                                             Not reported                                                                                CD should be considered in patients with unexplained movement disorders and seizures
                                                                                                                                                                                                                                                                         b) SEPs (median nerve)\                      b) Giant cortical response following stimulation of the affected side\                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                         e)\                                          c) No preceding cortical potential                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                         c) Jerk-locked back averaging                                                                                                                                                                                                                                                                                                    

  Hanagasi et al., [@B59]         1                                      F               31                             Ataxia, stimulus-induced myoclonus, eye movement abnormalities                                                                                   a\) EEG\                                     a\) Normal\                                                                                                                                                                             Myoclonus responded well to the diet                                                        CD as a cause of neurologic syndrome even without gastrointestinal symptoms
                                                                                                                                                                                                                                                                         b) BAEPs\                                    b) Normal\                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                         c) SEPs (tibial nerve)                       c) Normal                                                                                                                                                                                                                                                                           

  Bürk et al., [@B18]             12                                     7 F/5 M         Mean 55 (range 30-76)          Progressive cerebellar ataxia                                                                                                                    a\) BAEPs (10 patients)\                     a\) Abnormal BAEPs in 10%\                                                                                                                                                              Not reported                                                                                Evidence of dorsal column degeneration; less frequent involvement of central visual pathway
                                                                                                                                                                                                                                                                         b) VEPs (10 patients)\                       b) Abnormal VEPs in 30%\                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                         c) SEPs                                      c) Loss or delayed P40 response in 58.3%                                                                                                                                                                                                                                            

  Pratesi et al., [@B101]         1                                      M               3                              Drug-resistant epilepsy                                                                                                                          EEG                                          Slow background activity intermixed with frequent sharp and slow wave complexes                                                                                                         Progressive seizure control                                                                 Association between CD and refractory epilepsy

  Cakir et al., [@B21]            27                                     18 F/9 M        Mean 11.22 ± 4.27 (SD)         Asymptomatic; isolated seizure in 3                                                                                                              a\) EEG\                                     a\) Normal\                                                                                                                                                                             Subclinical neurological changes more common in non-compliant patients                      Subclinical neurological abnormalities are frequent in pediatric CD
                                                                                                                                                                                                                                                                         b) SEPs                                      b) Prolonged latencies in 3.7%                                                                                                                                                                                                                                                      

  Pawlak-Osińska et al., [@B93]   30                                     Not reported    Mean: 9.2 (range 6-18)         Gaze and optokinetic nystagmus in most of them                                                                                                   a\) BAEPs\                                   a\) Normal\                                                                                                                                                                             No response                                                                                 Neurological signs correlated with the histopathological changes
                                                                                                                                                                                                                                                                         b) VEMPs                                     b) Normal                                                                                                                                                                                                                                                                           

  Briani et al., [@B16]           71                                     16 M/55 F       Mean 36.7 ± 12.1 (SD)          Headache, depression, peripheral neuropathy, epilepsy (16 patients)                                                                              EEG                                          Not reported                                                                                                                                                                            No serological or electrophysiology change                                                  No clear correlation between anti-neural reactivity and neurologic dysfunction

  Sallem et al., [@B104]          1                                      F               46                             Generalized seizures, myoclonus, and ataxia                                                                                                      EEG (sleep and wake)                         Occasional generalized poly-spike wave complexes                                                                                                                                        No improvement                                                                              CD as a differential diagnosis of myoclonic ataxia and progressive cerebellar dysfunction

  Di Lazzaro et al., [@B42]       1                                      M               66                             Fatigability, painful cramps and mild weakness at left lower limb                                                                                SEPs (tibial nerve)                          Cortical responses bilaterally absent                                                                                                                                                   Clinical remission and improvement of SEPs                                                  Evidence of dorsal column involvement. Neurological symptoms even in older CD patients

  Licchetta et al., [@B76]        8                                      7 F/1 M         Mean 25.6 ± 4.85 (SD)          Progressive myoclonic epilepsy                                                                                                                   EEG (inter-ictal) and video-EEG monitoring   Focal posterior or diffuse spike-wave discharges; poly-spike-wave complexes                                                                                                             5 out of 7 patients did not respond                                                         CD as a cause of progressive myoclonic epilepsy. Peculiar involvement of the occipital lobe in CD

  Javed et al., [@B66]            1                                      F               63                             Late onset epilepsy, ataxia, tremor, progressive myoclonus                                                                                       a\) EEG\                                     a\) Right anterior and mid-temporal spike and waves, bilateral slow waves and sharp waves\                                                                                              No improvement                                                                              Refractory CD is linked to progressive neurological syndrome
                                                                                                                                                                                                                                                                         b) SEPs (tibial nerve)                       b) Giant cortical SEPs                                                                                                                                                                                                                                                              

  Parisi et al., [@B91]           2 (siblings)                           M/F             M: 5/F: 4                      M: seizures F: iron deficiency and poor growth                                                                                                   Awake and sleep EEG                          M: left temporal spike and wave discharges, generalized abnormal activity F: bursts of bilateral occipital spikes and diffuse polyspikes and sharp waves                                No improvement                                                                              A long follow-up may be required to clarify the relationships between clinical and EEG features

  Sarrigiannis et al., [@B105]    9                                      3 F/6 M         Mean 59.4 ± 10.4 (SD)          Asymmetrical irregular myoclonus at limbs and sometimes face; "Jacksonian march" (3 patients) and secondarily generalized seizure (5 patients)   a\) Standard EEG\                            a\) PLEDs, theta and delta activity (2 patients)\                                                                                                                                       Ataxia and enteropathy improved, but myoclonus remained the most disabling feature          The clinical involvement in CD covers the whole spectrum of cortical myoclonus
                                                                                                                                                                                                                                                                         b) SEPs\                                     b) Giant SEPs (5 patients)\                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                         c) Jerk-locked back averaging\               c) Cortical myoclonus\                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                         d) Long loop reflexes                        d) Altered long-loop reflexes (5 patients)                                                                                                                                                                                                                                          

  Casciato et al., [@B29]         10                                     9 F/1 M         Mean 31.5 (range 18-44)        Seizures                                                                                                                                         EEG                                          Slow and epileptiform abnormalities over parietal-occipital and temporal regions                                                                                                        Decrease of seizure frequency in half of patients                                           "Posterior" ictal semiology, EEG patterns and drug-resistance were peculiar features in CD

  Pennisi et al., [@B98]          20                                     16 F/4 M        Median 33.0 (range 24-45)      Dysthymic disorder (5 patients); anxiety (2 patients)                                                                                            a\) EEG\                                     a\) Normal\                                                                                                                                                                             GFD was not started yet (*de novo* patients)                                                Disinhibition and hyperfacilitation of the motor cortex. Immune system dysregulation might trigger changes of cortical excitability
                                                                                                                                                                                                                                                                         b) TMS                                       b) Shorter CSP, reduced ICI, enhanced ICF                                                                                                                                                                                                                                           

  Dai et al., [@B39]              2                                      1 F/1 M         M: 3 / F: 10                   Tonic-clonic seizures and mild intellectual disability                                                                                           EEG                                          Bilateral spikes and slow wave complexes in the occipital lobes, predominantly in the right hemisphere                                                                                  Not reported                                                                                CD is more common among patients with occipital lobe epilepsy (often drug-resistant)

  Işıkay et al., [@B64]           a\) 216 (newly diagnosed CD group);\   180 F/127 M     a\) Mean 10.15 ± 3.7 (SD)\     Headache in 2.9%                                                                                                                                 EEG                                          Epileptiform activity (spike/sharp-wave discharges) in 24 patients; among them, 21 (9.7%) were in newly diagnosed group and 3 (3.3%) in GFD group                                       Early strict GFD is advised in patients with epileptiform activities                        CD patients are prone to epileptiform activities
                                  b) 91 (GFD group                                       b) Mean 9.88 ± 4.2 (SD)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Işıkay et al., [@B65]           a\) 43 (newly diagnosed CD group)\     103 F/72 M      Mean 10.6 ± 3.8 (SD)           Headache in 31.4%                                                                                                                                EEG                                          Epileptiform activity in 9.3% of newly diagnosed CD patients and in 1.5% of formerly diagnosed patients                                                                                 Decrease of EEG epileptiform discharges                                                     Increased epileptiform activity among newly-diagnosed patients; tissue transglutaminase correlated with EEG
                                  b) 132 (formerly diagnosed group)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Parisi et al., [@B90]           19                                     16 F/3 M        Mean 9.82 ± 4.09 (SD)          Headache in 36.8%; positive OSA score in 31.6%                                                                                                   EEG                                          Focal or generalized sharps and/or spikes and spike-waves in 48% of children                                                                                                            Headache disappeared in 72% and EEG abnormalities in 78%; negative OSA score in all         Consider atypical or silent CD in case of unexplained symptoms, sleep breathing disorder or EEG abnormalities

  Bella et al., [@B10]            13                                     10 F/3 M        39 (range 24-46)               Dysthymic disorder (1 patient)                                                                                                                   TMS                                          Compared to the baseline (*de novo*):\                                                                                                                                                  Increased cortical excitability after a relatively short period of diet                     Functional cortical reorganization probably compensating for disease progression
                                                                                                                                                                                                                                                                                                                      - decrease of median rMT\                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                      - shorter CSP\                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                      - reduced ICI\                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                      - enhanced ICF                                                                                                                                                                                                                                                                      

  Aksoy et al., [@B3]             65                                     26 M/39 F       Mean 12.85 ± 4.23 (SD)         Intellectual disability (3 patient); ophtalmoplegia and distonia (1 patient)                                                                     a\) EEG\                                     a\) abnormal in 5 patients (focal temporal epileptic activity in 2, occipital in 1, and left hemisphere in 1; generalized in 1)\                                                        EEG improved in 3 out of 4 patients on GFD and antiepileptic drugs                          Increased risk of neurological abnormalities in atypical and silent forms that involves older ages and older ages at the diagnosis
                                                                                                                                                                                                                                                                         b) VEPs\                                     b) abnormal in 7 patients (marked and bilateral in 2)\                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                         c) BAEPs                                     c) abnormal in 1 patient (sensorineural hearing loss)                                                                                                                                                                                                                               

  Pennisi et al., [@B99]          a\) 20 *de novo* CD patients\          a\) 4 M/16 F\   a\) Mean 35.00 ± 12.03 (SD)\   a\) Dysthymic disorder (5 patients); higher score for depression, anxiety, and irritability\                                                     TMS                                          \- Shorter CSP in *de novo* patients than GFD patients\                                                                                                                                 A prolonged dietary regimen induced a recover of most but not all electrocortical changes   Subtle intracortical synaptic dysfunction may persist notwithstanding the GFD
                                  b) 20 CD patients on GFD               b) 6 M/14 F     b) Mean 35.10 ± 6.02 (SD)      b) Normal                                                                                                                                                                                     - Smaller motor response amplitude in all patients\                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                      - Reduced ICI and enhanced ICF in all patients\                                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                      - Increased ICF in gluten-restricted compared to non-restricted patients                                                                                                                                                                                                            
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*BAEPs, brainstem auditory evoked potentials; CD, Celiac disease; CSP, cortical silent period; EEG, electroencephalography; F, female; GFD, gluten-free diet; ICF, intracortical facilitation; ICI, intracortical inhibition; M, male; OSA, obstructive sleep apnea; PLEDs, Periodic Lateralized Epileptiform Discharges; rMT, resting motor threshold; SD, standard deviation; SEPs, somatosensory evoked potentials; TMS, transcranial magnetic stimulation; VEMPs, vestibular evoked myogenic potentials; VEPs, visual evoked potentials*.
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From a pure neurophysiological perspective, findings from EEG, SEPs, and TMS seem to converge on an overall profile of "hyperexcitable celiac brain," albeit this may not be confined to the cerebral cortex. Indeed, an increase in cerebral cortical excitability may arise from enhanced inputs from the cerebellum (Tijssen et al., [@B109]). In this context, it is important to remember that malabsorption syndrome (with the consequent deficiency of vitamins and other nutrients) probably does not account for these cortical manifestations, given that it takes place in the most severely affected patients whose intestinal mucosa are seriously damaged and do not recover after institution of a GFD (Pennisi et al., [@B98]).

Regarding humoral autoimmunity to neuronal antigens, deposits of anti-tTG2 and anti-tTG6 antibodies have been found not only in the small intestine but also in different CNS sites (cerebellum, pons, medulla, brain blood vessels) (Hadjivassiliou et al., [@B49]). Furthermore, a possible BBB lesion, secondary to diffuse infiltration of T-lymphocytes and inflammatory cells within the perivascular cuffing might expose cerebral tissues to antibodies (Hadjivassiliou et al., [@B57]). The result may be a vicious circle that eventually leads to a prevailing synaptic hyperexcitation and a weaker inhibition at the cortical level (Pennisi et al., [@B98]). The increased excitability may also be the correlate of a glutamate-induced cortical rearrangement or a dysfunctional control of GABAergic inhibitory interneurons. In particular, because glutamate is of pivotal importance in synaptic plasticity, it can be speculated that immune system dysregulation triggered by gluten ingestion, might result in a long-standing activation of post-synaptic glutamate receptors accounting for the enhanced hyperexcitability (Bella et al., [@B10]).

The neurophysiological-based approach to CD should take into account potential pitfalls and critical aspects related to both the techniques themselves and methodological biases in the studies reviewed here. First, as mentioned, electrophysiological changes are not disease-specific. Second, an association finding does not mean causative relationship. For instance, an association between CD and amyotrophic lateral sclerosis was previously reported in different investigations (Turner et al., [@B111], [@B112]; Brown et al., [@B17]; Bersano et al., [@B11]; Gadoth et al., [@B45]) but not confirmed in a large population-based cohort study (Ludvigsson et al., [@B80]). Finally, it is mandatory to make a differential diagnosis between hyperexcitability-related seizures and incidental EEG findings in neurologically asymptomatic CD subjects. In the latter case, EEG changes represent a confounding factor and a long follow-up is required (Parisi et al., [@B91]).

The response of neurological symptoms to a GFD is still controversial. Current knowledge encompasses an initial phase when patients are "gluten-sensitive" and a subsequent stage characterized by "gluten-insensitivity" (Tursi et al., [@B113]). An older age at diagnosis or a prolonged period of gluten ingestion may account for persistent neurological symptoms after a relatively short period of GFD (Bella et al., [@B10]). Moreover, gluten restriction is not usually effective in patients with refractory CD and in those with an associated autoimmune disease or some neurological complications (Hadjivassiliou et al., [@B57]; Castillo et al., [@B31]; Campagna et al., [@B22]). It is reasonable to conclude that some neurological aspects improve after diet restriction whereas others persist, supporting the concept that the more prolonged the GFD, the more likely clinical and neurophysiological remission may occur. However, given that neurological impairment may develop despite an adequate adherence to a GFD (Luostarinen et al., [@B82]; Chin and Latov, [@B32]; Tursi et al., [@B113]; Bürk et al., [@B19]), other causative factors have to contribute (McKeon et al., [@B85]): (a) accidental minimal gluten contamination despite a good dietary compliance (Green and Jabri, [@B48]); (b) direct gliadin-mediated inflammatory attack; (c) other components that are independent of GFD (Tijssen et al., [@B109]).

Based on further understanding of the pathogenesis and treatment of CD, neurophysiology-targeted non-dietary therapies are in development (Schuppan et al., [@B106]). Similarly, modern rehabilitation approach involves organizational measures that promote not only clinical recovery but also a better quality of life (Sabel\'nikova et al., [@B103]) through the support of different medical and non-medical specialists (Usanova et al., [@B115]).

In conclusion, neurophysiology, together with clinical, serological, and imaging data, can help in disentangling the multifaceted physiopathological and neurobiological mechanisms coupling gut and brain in CD. The eventual identification of neurophysiological markers might be useful in the diagnosis and monitoring of CD, aiming to improve the healthcare of both single subjects and the global community.
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